Adnan Aydiner MD, Institute of Oncology, Istanbul Medical Faculty, Department of Medical Oncology, Istanbul University, Istanbul, Turkey. Professor of Medical Oncology and Internal Medicine. He is a member of many International Societies and is the Board Member of Istanbul University, Oncology Institute. He is the President of Clinical Oncology Society and the President of Lung Cancer Society in Turkey. He is a Board Member of Istanbul Breast Society. He is one of the principal investigators in many International trials and he has published over 130 peer-review papers. He is one of the editors of Breast Disease book (by Springer), and also the editor of more than 15 books. Abdullah Igci MD, FACS, Istanbul Medical Faculty, Department of General Surgery, Breast Unit, Istanbul University, Istanbul, Turkey. Professor of Surgery. Director, Turkey Breast Disease Federation; Director, Istanbul Breast Society. He has published over 55 peer-review papers, heis one of the editors of Breast Disease book (by Springer).Atilla Soran MD, MPH, FACS, Department of Breast Surgery, Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburg, USA. Professor of Surgery; Director, International Breast Fellowship Program; Director, Lymphedema Program; Director, Clinical Research for Breast Disease; Director, Breast Disease Clinical Research Program; Director, International Breast Fellowship Program; Director, Comprehensive Lymphedema Center; Chair, International Committee National Consortium of Breast Centers. He has published over 80 peer-review papers, he is one of the editors of Breast Disease book (by Springer).

“This excellent book is to be recommended to the breast multidisciplinary team as a comprehensive overview of both accepted diagnostic and treatment pathways and current ‘hot topics’ with recent trials and advances in all disciplines explored and well referenced.” (Janet Litherland, RAD Magazine, August, 2019)

• 1. Decision Pathways In Breast Cancer Management.- 2. Pathology of Breast Dısease.- 2-1Pathology of Breast Cancer.- 2.2 Mesenchymal and Fibroepithelial Tumors of The Breast.- 2.3 Intraoperative Pathological Examination of Breast Lesions.- 2.4 Prognostic and Predictive Factors.- 3. Breast Imaging.- 4. Surgical Approach for Breast Cancer.- 5. Adjuvant Systemic Therapy for Breast Cancer.- 5.1 Adjuvant Chemotherapy for Her-2 Negative Breast Cancer.- 5.2 Adjuvant Therapy for Her2-Positive Early-Stage Breast Cancer.- 5.3 Adjuvant Endocrine Therapy.- 6. Adjuvant Radiation Therapy.- 7. Preoperative Systemic Therapy For Breast Cancer.- 7.1 Preoperative Therapy for Operable Breast Cancer.- 7.2 Preoperative Systemic Therapy: Locally Advanced Breast Cancer.- 7.3 Inflammatory Breast Cancer.- 8. Systemic Therapy for Metastatic Breast Cancer.- 8.1  Her2-Negative Metastatic Breast Cancer.- 8.2  Her2-Overexpressing Metastatic Breast Cancer.- 8.3  Hormone Receptor Positive Metastatic Breast Cancer.- 9.Biostatistical and Epidemiological Terms Frequently Used In Breast Disease Research.

Adnan Aydiner MD, Institute of Oncology, Istanbul Medical Faculty, Department of Medical Oncology, Istanbul University, Istanbul, Turkey. Professor of Medical Oncology and Internal Medicine. He is a member of many International Societies and is the Board Member of Istanbul University, Oncology Institute. He is the President of Clinical Oncology Society and the President of Lung Cancer Society in Turkey. He is a Board Member of Istanbul Breast Society. He is one of the principal investigators in many International trials and he has published over 130 peer-review papers. He is one of the editors of Breast Disease book (by Springer), and also the editor of more than 15 books. Abdullah Igci MD, FACS, Istanbul Medical Faculty, Department of General Surgery, Breast Unit, Istanbul University, Istanbul, Turkey. Professor of Surgery. Director, Turkey Breast Disease Federation; Director, Istanbul Breast Society. He has published over 55 peer-review papers, heis one of the editors of Breast Disease book (by Springer).Atilla Soran MD, MPH, FACS, Department of Breast Surgery, Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburg, USA. Professor of Surgery; Director, International Breast Fellowship Program; Director, Lymphedema Program; Director, Clinical Research for Breast Disease; Director, Breast Disease Clinical Research Program; Director, International Breast Fellowship Program; Director, Comprehensive Lymphedema Center; Chair, International Committee National Consortium of Breast Centers. He has published over 80 peer-review papers, he is one of the editors of Breast Disease book (by Springer).

“This excellent book is to be recommended to the breast multidisciplinary team as a comprehensive overview of both accepted diagnostic and treatment pathways and current ‘hot topics’ with recent trials and advances in all disciplines explored and well referenced.” (Janet Litherland, RAD Magazine, August, 2019)

• 1. Decision Pathways In Breast Cancer Management.- 2. Pathology of Breast Dısease.- 2-1Pathology of Breast Cancer.- 2.2 Mesenchymal and Fibroepithelial Tumors of The Breast.- 2.3 Intraoperative Pathological Examination of Breast Lesions.- 2.4 Prognostic and Predictive Factors.- 3. Breast Imaging.- 4. Surgical Approach for Breast Cancer.- 5. Adjuvant Systemic Therapy for Breast Cancer.- 5.1 Adjuvant Chemotherapy for Her-2 Negative Breast Cancer.- 5.2 Adjuvant Therapy for Her2-Positive Early-Stage Breast Cancer.- 5.3 Adjuvant Endocrine Therapy.- 6. Adjuvant Radiation Therapy.- 7. Preoperative Systemic Therapy For Breast Cancer.- 7.1 Preoperative Therapy for Operable Breast Cancer.- 7.2 Preoperative Systemic Therapy: Locally Advanced Breast Cancer.- 7.3 Inflammatory Breast Cancer.- 8. Systemic Therapy for Metastatic Breast Cancer.- 8.1  Her2-Negative Metastatic Breast Cancer.- 8.2  Her2-Overexpressing Metastatic Breast Cancer.- 8.3  Hormone Receptor Positive Metastatic Breast Cancer.- 9.Biostatistical and Epidemiological Terms Frequently Used In Breast Disease Research.

Adnan Aydiner MD, Institute of Oncology, Istanbul Medical Faculty, Department of Medical Oncology, Istanbul University, Istanbul, Turkey. Professor of Medical Oncology and Internal Medicine. He is a member of many International Societies and is the Board Member of Istanbul University, Oncology Institute. He is the President of Clinical Oncology Society and the President of Lung Cancer Society in Turkey. He is a Board Member of Istanbul Breast Society. He is one of the principal investigators in many International trials and he has published over 130 peer-review papers. He is one of the editors of Breast Disease book (by Springer), and also the editor of more than 15 books. Abdullah Igci MD, FACS, Istanbul Medical Faculty, Department of General Surgery, Breast Unit, Istanbul University, Istanbul, Turkey. Professor of Surgery. Director, Turkey Breast Disease Federation; Director, Istanbul Breast Society. He has published over 55 peer-review papers, heis one of the editors of Breast Disease book (by Springer).Atilla Soran MD, MPH, FACS, Department of Breast Surgery, Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburg, USA. Professor of Surgery; Director, International Breast Fellowship Program; Director, Lymphedema Program; Director, Clinical Research for Breast Disease; Director, Breast Disease Clinical Research Program; Director, International Breast Fellowship Program; Director, Comprehensive Lymphedema Center; Chair, International Committee National Consortium of Breast Centers. He has published over 80 peer-review papers, he is one of the editors of Breast Disease book (by Springer).

“This excellent book is to be recommended to the breast multidisciplinary team as a comprehensive overview of both accepted diagnostic and treatment pathways and current ‘hot topics’ with recent trials and advances in all disciplines explored and well referenced.” (Janet Litherland, RAD Magazine, August, 2019)

• 1. Decision Pathways In Breast Cancer Management.- 2. Pathology of Breast Dısease.- 2-1Pathology of Breast Cancer.- 2.2 Mesenchymal and Fibroepithelial Tumors of The Breast.- 2.3 Intraoperative Pathological Examination of Breast Lesions.- 2.4 Prognostic and Predictive Factors.- 3. Breast Imaging.- 4. Surgical Approach for Breast Cancer.- 5. Adjuvant Systemic Therapy for Breast Cancer.- 5.1 Adjuvant Chemotherapy for Her-2 Negative Breast Cancer.- 5.2 Adjuvant Therapy for Her2-Positive Early-Stage Breast Cancer.- 5.3 Adjuvant Endocrine Therapy.- 6. Adjuvant Radiation Therapy.- 7. Preoperative Systemic Therapy For Breast Cancer.- 7.1 Preoperative Therapy for Operable Breast Cancer.- 7.2 Preoperative Systemic Therapy: Locally Advanced Breast Cancer.- 7.3 Inflammatory Breast Cancer.- 8. Systemic Therapy for Metastatic Breast Cancer.- 8.1  Her2-Negative Metastatic Breast Cancer.- 8.2  Her2-Overexpressing Metastatic Breast Cancer.- 8.3  Hormone Receptor Positive Metastatic Breast Cancer.- 9.Biostatistical and Epidemiological Terms Frequently Used In Breast Disease Research.